CIK 0000882796 · Large accelerated filer
BIOCRYST PHARMACEUTICALS INC
Sign in to watch- Ticker
- BCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 621413174
- Phone
- 919-859-1302
- Business address
- 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-07 | LEVIN ALAN G Director | Grant or award · Automatic Stock Option Grant | +30,022 | 30,022 | ||
| 2022-06-07 | LEE KENNETH B JR Director | Grant or award | +12,866 | 37,118 | ||
| 2022-06-07 | LEE KENNETH B JR Director | Grant or award · Automatic Stock Option Grant | +30,022 | 30,022 | ||
| 2022-06-07 | Galson Steven K Director | Grant or award | +12,866 | 12,866 | ||
| 2022-06-07 | Galson Steven K Director | Grant or award · Automatic Stock Option Grant | +30,022 | 30,022 | ||
| 2022-06-07 | ASELAGE STEVE Director | Grant or award | +12,866 | 46,594 | ||
| 2022-06-07 | ASELAGE STEVE Director | Grant or award · Automatic Stock Option Grant | +30,022 | 30,022 | ||
| 2022-05-31 | ASELAGE STEVE Director | Grant or award | +569 | $9.31 | $5K | 33,728 |
| 2022-05-31 | HEGGIE THERESA Director | Grant or award | +1,138 | $9.31 | $11K | 17,363 |
| 2022-05-31 | LEVIN ALAN G Director | Grant or award | +1,138 | $9.31 | $11K | 3,197 |
| 2022-05-31 | INGRAM ROBERT ALEXANDER Director | Grant or award | +2,078 | $9.31 | $19K | 82,138 |
| 2022-04-18 | ABERCROMBIE GEORGE B Director | Option exercise | +5,000 | $3.32 | $17K | 5,000 |
| 2022-04-18 | ABERCROMBIE GEORGE B Director | Sale | −5,000 | $11.04 | $55K | 0 |
| 2022-04-18 | ABERCROMBIE GEORGE B Director | Option exercise · Automatic Stock Option Grant | −5,000 | 0 | ||
| 2022-04-01 | Thackray Helen M. Chief R&D Officer | Sale | −7,600 | $16.20 | $123K | 136,400 |
| 2022-03-10 | Sheridan William P Chief Medical Officer | Option exercise | +148,302 | $3.22 | $478K | 199,093 |
| 2022-03-10 | Sheridan William P Chief Medical Officer | Sale | −159,739 | $16.87 | $2.7M | 39,354 |
| 2022-03-10 | Sheridan William P Chief Medical Officer | Sale | −1,400 | $17.64 | $25K | 37,954 |
| 2022-03-10 | Sheridan William P Chief Medical Officer | Option exercise · Emp. Stock Option (Right to Buy) | −148,302 | 0 | ||
| 2022-03-07 | Babu Yarlagadda S Chief Discovery Officer | Sale | −20,000 | $17.16 | $343K | 230,056 |
Page 16 of 18 · 357 trades